These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9572411)

  • 1. The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization.
    Devroey P; Tournaye H; Van Steirteghem A; Hendrix P; Out HJ
    Hum Reprod; 1998 Mar; 13(3):565-6. PubMed ID: 9572411
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study.
    Tulppala M; Aho M; Tuuri T; Vilska S; Foudila T; Hakala-Ala-Pietilä T; Moilanen J; Bützow T; Kaukoranta S; Söderström-Anttila V; Siegberg R; Suikkari AM; Hovatta O
    Hum Reprod; 1999 Nov; 14(11):2709-15. PubMed ID: 10548606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.
    Jansen CA; van Os HC; Out HJ; Coelingh Bennink HJ
    Hum Reprod; 1998 Nov; 13(11):2995-9. PubMed ID: 9853844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization.
    Lisi F; Rinaldi L; Fishel S; Lisi R; Pepe G; Picconeri MG
    Fertil Steril; 2003 Apr; 79(4):1037-8. PubMed ID: 12749452
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial.
    Hedon B; Out HJ; Hugues JN; Camier B; Cohen J; Lopes P; Zorn JR; van der Heijden B; Coelingh Bennink HJ
    Hum Reprod; 1995 Dec; 10(12):3102-6. PubMed ID: 8822422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.
    Out HJ; Mannaerts BM; Driessen SG; Bennink HJ
    Hum Reprod; 1995 Oct; 10(10):2534-40. PubMed ID: 8567765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New stimulation regimens with recombinant FSH (Puregon) in in-vitro fertilization.
    Out HJ
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):21-2. PubMed ID: 10428317
    [No Abstract]   [Full Text] [Related]  

  • 10. What are the clinical benefits of recombinant gonadotrophins? Is Puregon a 'good' or'super' drug?
    Meniru GI
    Hum Reprod; 1999 Jun; 14(6):1409-11. PubMed ID: 10357947
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergoing controlled ovarian stimulation: prospective randomised double-blind study.
    Ng EY; Yeung WS; Ho PC
    Hong Kong Med J; 2000 Dec; 6(4):368-74. PubMed ID: 11177158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reproductive health--new hormonal agents to treat infertility].
    Popova B
    Akush Ginekol (Sofiia); 2002; 41 Suppl 1():23-31. PubMed ID: 12412351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of recombinant human luteinizing hormone for ovulation stimulation in in vitro fertilization-embryo transfer].
    Xu SR; Li Y; Liu H; Li HY; Tang R; Gao Q; Sheng Y; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):420-3. PubMed ID: 21029591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome from consecutive in-vitro fertilization/intracytoplasmic sperm injection attempts in the final group treated with urinary gonadotrophins and the first group treated with recombinant follicle stimulating hormone.
    Jacob S; Drudy L; Conroy R; Harrison RF
    Hum Reprod; 1998 Jul; 13(7):1783-7. PubMed ID: 9740423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.
    Out HJ; Bennink HJ; de Laat WN
    Hum Reprod; 1999 Sep; 14(9):2189-90. PubMed ID: 10469679
    [No Abstract]   [Full Text] [Related]  

  • 20. Full-term delivery following intracytoplasmic sperm injection with spermatozoa extracted from frozen-thawed testicular tissue.
    Khalifeh FA; Sarraf M; Dabit ST
    Hum Reprod; 1997 Jan; 12(1):87-8. PubMed ID: 9043909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.